1. Home
  2. RGEN vs KEP Comparison

RGEN vs KEP Comparison

Compare RGEN & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • KEP
  • Stock Information
  • Founded
  • RGEN 1981
  • KEP 1961
  • Country
  • RGEN United States
  • KEP South Korea
  • Employees
  • RGEN N/A
  • KEP N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • KEP Electric Utilities: Central
  • Sector
  • RGEN Health Care
  • KEP Utilities
  • Exchange
  • RGEN Nasdaq
  • KEP Nasdaq
  • Market Cap
  • RGEN 7.6B
  • KEP 8.9B
  • IPO Year
  • RGEN N/A
  • KEP N/A
  • Fundamental
  • Price
  • RGEN $156.55
  • KEP $6.91
  • Analyst Decision
  • RGEN Buy
  • KEP
  • Analyst Count
  • RGEN 12
  • KEP 0
  • Target Price
  • RGEN $187.44
  • KEP N/A
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • KEP 243.3K
  • Earning Date
  • RGEN 02-19-2025
  • KEP 03-01-2025
  • Dividend Yield
  • RGEN N/A
  • KEP N/A
  • EPS Growth
  • RGEN N/A
  • KEP N/A
  • EPS
  • RGEN N/A
  • KEP 4.40
  • Revenue
  • RGEN $633,513,000.00
  • KEP $70,353,349,144.00
  • Revenue This Year
  • RGEN $2.28
  • KEP $6.81
  • Revenue Next Year
  • RGEN $9.88
  • KEP $4.78
  • P/E Ratio
  • RGEN N/A
  • KEP $3.14
  • Revenue Growth
  • RGEN N/A
  • KEP 8.48
  • 52 Week Low
  • RGEN $113.50
  • KEP $6.68
  • 52 Week High
  • RGEN $211.13
  • KEP $9.55
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • KEP 38.87
  • Support Level
  • RGEN $149.15
  • KEP $6.82
  • Resistance Level
  • RGEN $160.64
  • KEP $7.09
  • Average True Range (ATR)
  • RGEN 5.96
  • KEP 0.10
  • MACD
  • RGEN 0.91
  • KEP 0.03
  • Stochastic Oscillator
  • RGEN 79.57
  • KEP 45.92

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About KEP Korea Electric Power Corporation

Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment.

Share on Social Networks: